Page last updated: 2024-11-02

phenylmethylsulfonyl fluoride and Cancer of Prostate

phenylmethylsulfonyl fluoride has been researched along with Cancer of Prostate in 1 studies

Phenylmethylsulfonyl Fluoride: An enzyme inhibitor that inactivates IRC-50 arvin, subtilisin, and the fatty acid synthetase complex.
phenylmethanesulfonyl fluoride : An acyl fluoride with phenylmethanesulfonyl as the acyl group.

Research Excerpts

ExcerptRelevanceReference
"The standard therapy for advanced prostate cancer is androgen ablation."1.28Cyclic AMP induces transforming growth factor beta 2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3. ( Bang, YJ; Danielpour, D; Kim, KY; Kim, SJ; Myers, CE; O'Reilly, MA; Trepel, JB, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bang, YJ1
Kim, SJ1
Danielpour, D1
O'Reilly, MA1
Kim, KY1
Myers, CE1
Trepel, JB1

Other Studies

1 other study available for phenylmethylsulfonyl fluoride and Cancer of Prostate

ArticleYear
Cyclic AMP induces transforming growth factor beta 2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3.
    Proceedings of the National Academy of Sciences of the United States of America, 1992, Apr-15, Volume: 89, Issue:8

    Topics: 1-Methyl-3-isobutylxanthine; Aprotinin; Blotting, Northern; Bucladesine; Cell Division; Cell Line; C

1992